NEXVET BIOPHARMA PUB LTD CO - ORD SHS (NVET)

CUSIP: G6503X109

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / ORD SHS
Total 13F shares
5,791,550
Share change
-272,867
Total reported value
$19,749,000
Price per share
$3.41
Number of holders
19
Value change
-$1,004,943
Number of buys
8
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP G6503X109?
CUSIP G6503X109 identifies NVET - NEXVET BIOPHARMA PUB LTD CO - ORD SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEXVET BIOPHARMA PUB LTD CO - ORD SHS (NVET) as of Q4 2015

As of 31 Dec 2015, NEXVET BIOPHARMA PUB LTD CO - ORD SHS (NVET) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,791,550 shares. The largest 10 holders included FARALLON CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP LLC, Foresite Capital Management II, LLC, Broadfin Capital, LLC, WELLINGTON MANAGEMENT GROUP LLP, Boxer Capital, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, NORGES BANK, PANAGORA ASSET MANAGEMENT INC, and COWEN GROUP, INC.. This page lists 19 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.